Walleye Capital’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $902K | Sell |
64,556
-39,461
| -38% | -$552K | ﹤0.01% | 875 |
|
|
2025
Q1 | $1.4M | Sell |
104,017
-377,622
| -78% | -$5.09M | 0.01% | 731 |
|
|
2024
Q4 | $9.23M | Sell |
481,639
-78,368
| -14% | -$1.5M | 0.02% | 277 |
|
|
2024
Q3 | $12.7M | Buy |
560,007
+129,411
| +30% | +$2.94M | 0.03% | 218 |
|
|
2024
Q2 | $5.6M | Buy |
430,596
+424,960
| +7,540% | +$5.53M | 0.01% | 440 |
|
|
2024
Q1 | $98.7K | Sell |
5,636
-235,775
| -98% | -$4.13M | ﹤0.01% | 2011 |
|
|
2023
Q4 | $5.26M | Buy |
241,411
+227,881
| +1,684% | +$4.96M | 0.01% | 341 |
|
|
2023
Q3 | $208K | Sell |
13,530
-73,590
| -84% | -$1.13M | ﹤0.01% | 1479 |
|
|
2023
Q2 | $2.07M | Sell |
87,120
-29,537
| -25% | -$703K | 0.01% | 505 |
|
|
2023
Q1 | $2.97M | Buy |
116,657
+70,515
| +153% | +$1.79M | 0.04% | 405 |
|
|
2022
Q4 | $1.35M | Sell |
46,142
-143,387
| -76% | -$4.19M | 0.02% | 596 |
|
|
2022
Q3 | $3.89M | Buy |
189,529
+11,078
| +6% | +$227K | 0.07% | 264 |
|
|
2022
Q2 | $2.07M | Buy |
178,451
+16,170
| +10% | +$187K | 0.06% | 350 |
|
|
2022
Q1 | $3M | Buy |
162,281
+52,106
| +47% | +$964K | 0.08% | 243 |
|
|
2021
Q4 | $2.18M | Buy |
110,175
+87,674
| +390% | +$1.73M | 0.07% | 303 |
|
|
2021
Q3 | $370 | Buy |
+22,501
| New | +$370 | 0.01% | 902 |
|